Drug · DIN 02239367
TEVA-SUMATRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 29, 2011; first marketed September 30, 2005.
- Drug Identification Number (DIN)
- 02239367
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 28, 2011: NOC 12470Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- August 24, 2005: NOC 7318Abbreviated New Drug Submission (ANDS)